GSB Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
1,103
+107
| +11% | +$43.4K | 0.11% | 148 |
|
|
2025
Q1 | $496K | Sell |
996
-23
| -2% | -$11.4K | 0.13% | 137 |
|
|
2024
Q4 | $530K | Sell |
1,019
-18
| -2% | -$9.37K | 0.14% | 137 |
|
|
2024
Q3 | $642K | Hold |
1,037
| – | – | 0.16% | 126 |
|
|
2024
Q2 | $573K | Hold |
1,037
| – | – | 0.16% | 133 |
|
|
2024
Q1 | $603K | Sell |
1,037
-100
| -9% | -$58.1K | 0.17% | 130 |
|
|
2023
Q4 | $604K | Hold |
1,137
| – | – | 0.19% | 125 |
|
|
2023
Q3 | $576K | Buy |
1,137
+11
| +1% | +$5.57K | 0.19% | 121 |
|
|
2023
Q2 | $588K | Hold |
1,126
| – | – | 0.19% | 125 |
|
|
2023
Q1 | $649K | Sell |
1,126
-30
| -3% | -$17.3K | 0.21% | 127 |
|
|
2022
Q4 | $637K | Sell |
1,156
-1,005
| -47% | -$553K | 0.23% | 127 |
|
|
2022
Q3 | $1.1M | Sell |
2,161
-81
| -4% | -$41.1K | 0.4% | 92 |
|
|
2022
Q2 | $1.22M | Hold |
2,242
| – | – | 0.42% | 91 |
|
|
2022
Q1 | $1.32M | Hold |
2,242
| – | – | 0.39% | 91 |
|
|
2021
Q4 | $1.5M | Buy |
2,242
+472
| +27% | +$315K | 0.43% | 82 |
|
|
2021
Q3 | $1.01M | Sell |
1,770
-512
| -22% | -$292K | 0.52% | 59 |
|
|
2021
Q2 | $1.15M | Buy |
2,282
+170
| +8% | +$85.7K | 0.36% | 90 |
|
|
2021
Q1 | $964K | Buy |
+2,112
| New | +$964K | 0.32% | 98 |
|